Replies to post #305613 on Avid Bioservices Inc (CDMO)

[ArchieK]

Do we know that BBs are NOT being used/tested? I speculate they are.

[eb0783]

BBs are the foundation of our exosome platform. See CJ’s post earlier: http://investorshub.advfn.com/boards/read_msg.aspx?message_id=132992356
Quote:

”Detection of Phosphatidylserine-Positive Exosomes for the Diagnosis of Early-Stage Malignancies [Using Betabody KL15C]

I might mention/remind you that Ronin saw fit to ignore this altogether. Hmmm?

[goodJohnhunting]

GJH

You keep saying that bavi is a clumsy molecule. Would BBs be better in your opinion and if so why do you think they are not choosing to get it out there.

BB's will not change the "elephant in the room" (Endogenous Protein Cross Reactivity), IMO.

Chemo produces more competition for anti-ps and thus the laws of diminishing returns. What needs to happen is a reduction in receptor site competition. In one such theory, statins would eliminate "marginal" competition, IMO.

The question is how much is marginal, and what therapeutic significance would be achieved?

All the best,
John